Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.

Histology and histopathology - 1 Aug 2018

Haapasalo Joonas, Nordfors Kristiina, Granberg Kirsi J, Kivioja Tomi, Nykter Matti, Haapasalo Hannu, Soini Ylermi

Abstract excerpt

Nuclear factor erythroid 2-related factor 2 (NRF2), DJ1 and sulfiredoxin 1 (SRXN1) are transcription factors which protect cells from the oxidative damage caused by reactive oxygen species and, on the other hand, are associated with resistance to cancer treatments. The immunohistochemical expression of NRF2, DJ1 and SRNX1 was assessed in human grade II-IV astrocytic gliomas. Their association to clinicopathologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Glioblastoma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to NF-E2-Related Factor 2

Share to Oxidoreductases Acting on Sulfur Group Donors

Share to Proportional Hazards Models

Share to Protein Deglycase DJ-1

Source

Identifiers

PMID: 29441509
DOI: 10.14670/HH-11-973

Genes

IDH1
SRXN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.PMID 29441509Read ↗

Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of GlioblastomaSemantic proximity Read ↗

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.Semantic proximity Read ↗

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.Semantic proximity Read ↗

Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.Semantic proximity Read ↗

Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.Semantic proximity Read ↗

The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population.Semantic proximity Read ↗

New Clues in the Malignant Progression of Glioblastoma: Can the Thioredoxin System Play a Role?Semantic proximity Read ↗

Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cells.Semantic proximity Read ↗

Brg1 mutation alters oxidative stress responses in glioblastoma.Semantic proximity Read ↗

Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK Study.Semantic proximity Read ↗

CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1α under hypoxic conditionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.